|
Resverlogix Announces Loan Reduction and Extension
|
1
|
Resverlogix Corp.
|
Aug 02, 2019 12:15PM
|
|
Where's the Money Coming From; FDA Fast Track Information
|
2
|
BIOASIS TECHNOLOGIES INC
|
Aug 01, 2019 09:36AM
|
|
Re: Warrants
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 05:34PM
|
|
Re: Warrants
|
4
|
Resverlogix Corp.
|
Jul 31, 2019 05:06PM
|
|
Re: Sedar filings - Loan balance
|
2
|
Resverlogix Corp.
|
Jul 31, 2019 01:13PM
|
|
Re: Couple interesting tidbits from Financials
|
7
|
Resverlogix Corp.
|
Jul 30, 2019 11:05AM
|
|
Re: Couple interesting tidbits from Financials
|
5
|
Resverlogix Corp.
|
Jul 30, 2019 10:42AM
|
|
Re: Couple interesting tidbits from Financials
|
7
|
Resverlogix Corp.
|
Jul 30, 2019 08:42AM
|
|
Publications!
|
9
|
Resverlogix Corp.
|
Jul 30, 2019 08:37AM
|
|
Re: Is Resverlogix Legit?
|
2
|
Resverlogix Corp.
|
Jul 28, 2019 12:29PM
|
|
Re: Is Resverlogix Legit?
|
6
|
Resverlogix Corp.
|
Jul 28, 2019 08:36AM
|
|
MD&A and Financials
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 28, 2019 08:27AM
|
|
Re: NLRP3 inhibitors and apabetalone
|
5
|
Resverlogix Corp.
|
Jul 26, 2019 02:28PM
|
|
NLRP3 inhibitors and apabetalone
|
8
|
Resverlogix Corp.
|
Jul 26, 2019 01:10PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
5
|
Zenith Epigenetics
|
Jul 25, 2019 02:50PM
|
|
July Corporate Update
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 25, 2019 02:41PM
|
|
Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV
|
3
|
Resverlogix Corp.
|
Jul 24, 2019 03:20PM
|
|
BRD4/Nrf2/ARE signaling is implicated in the pathogenesis of diabetic nephropathy
|
4
|
Resverlogix Corp.
|
Jul 24, 2019 02:59PM
|
|
Re: Contest Tally - Cut Off Tonight 9 pm EST
|
6
|
Resverlogix Corp.
|
Jul 23, 2019 12:19PM
|
|
Re: What's going on with the Phase 2 ZEN-3694 mCRPC trial?
|
6
|
Zenith Epigenetics
|
Jul 22, 2019 10:17AM
|
